TR199901702T2 - N-Sulfonilindolin türevleri içeren farmasötik bilesimler. - Google Patents

N-Sulfonilindolin türevleri içeren farmasötik bilesimler.

Info

Publication number
TR199901702T2
TR199901702T2 TR1999/01702T TR9901702T TR199901702T2 TR 199901702 T2 TR199901702 T2 TR 199901702T2 TR 1999/01702 T TR1999/01702 T TR 1999/01702T TR 9901702 T TR9901702 T TR 9901702T TR 199901702 T2 TR199901702 T2 TR 199901702T2
Authority
TR
Turkey
Prior art keywords
sulfonilindolin
revleri
farmas
imler
tik
Prior art date
Application number
TR1999/01702T
Other languages
English (en)
Inventor
Gautier Jean-Claude
John Fuller Simon
Original Assignee
Sanofi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi filed Critical Sanofi
Publication of TR199901702T2 publication Critical patent/TR199901702T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Mevcut bulus, formül I N-sulfonilindolin hidrofobik türevlerinin çözünürlügü için, suda emülsiflesebilen veya mikro emülsiflesebilen bir susuz çözücü/dengeleyici sistemle ilgili olup özelligi, amfifilik bilesikler, ve iyonik olmayan hidrofilik yüzey aktif maddeleri ve hem amfifilik ve hem de yüzey aktif özellikleri olan iyonik olmayan hidrofilik bilesiklerden seçilen bir veya daha fazla bilesen içermesidir, yani, bahsedilen sistem ya en az bir amfifilik bilesik ve iyonik olmayan hidrofilik yüzey aktif karisimi, veya en az bir hem yüzey aktif ve amfifilik özelikleri olan iyonik olmayan hidrofilik bilesik içerir.
TR1999/01702T 1996-12-05 1997-12-04 N-Sulfonilindolin türevleri içeren farmasötik bilesimler. TR199901702T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9614957A FR2756736B1 (fr) 1996-12-05 1996-12-05 Compositions pharmaceutiques contenant des derives de n-sulfonyl indoline

Publications (1)

Publication Number Publication Date
TR199901702T2 true TR199901702T2 (tr) 1999-09-21

Family

ID=9498376

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01702T TR199901702T2 (tr) 1996-12-05 1997-12-04 N-Sulfonilindolin türevleri içeren farmasötik bilesimler.

Country Status (25)

Country Link
EP (1) EP0941090A1 (tr)
JP (1) JP2000507618A (tr)
KR (1) KR20000069308A (tr)
CN (1) CN1239887A (tr)
AR (1) AR009651A1 (tr)
AU (1) AU716575B2 (tr)
BR (1) BR9712406A (tr)
CA (1) CA2273990A1 (tr)
CO (1) CO4910129A1 (tr)
DZ (1) DZ2362A1 (tr)
EE (1) EE9900206A (tr)
FR (1) FR2756736B1 (tr)
HU (1) HUP0001386A3 (tr)
ID (1) ID23373A (tr)
IL (1) IL129936A0 (tr)
IS (1) IS5062A (tr)
MY (1) MY132819A (tr)
NO (1) NO992724D0 (tr)
NZ (1) NZ335750A (tr)
RU (1) RU2174394C2 (tr)
SK (1) SK75599A3 (tr)
TR (1) TR199901702T2 (tr)
WO (1) WO1998024430A1 (tr)
YU (1) YU23099A (tr)
ZA (1) ZA9710919B (tr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2786486B3 (fr) * 1998-11-16 2000-12-08 Sanofi Sa Procede de preparation du (2s)-1-[(2r,3s)-5-chloro-3-(2- chlorophenyl)-1-(3,4-dimethoxy benzenesulfonyl)-3-hydroxy- 2,3-dihydro-1h-indole-2-carbonyl]pyrrolidine-2-carboxamide, de ses solvats et/ou hydrates
DE19913692A1 (de) * 1999-03-25 2000-09-28 Basf Ag Mechanisch stabile pharmazeutische Darreichungsformen, enthaltend flüssige oder halbfeste oberflächenaktive Substanzen
US6437006B1 (en) 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
EP1175205B1 (en) 1999-11-12 2006-06-14 Abbott Laboratories Solid dispersion comprising ritonavir, fenofibrate or griseofulvin
FR2805992A1 (fr) * 2000-03-08 2001-09-14 Sanofi Synthelabo Compositions pharmaceutiques orales contenant des derives de n-sulfonylindoline
DE10026698A1 (de) 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
ITMI20011338A1 (it) * 2001-06-26 2002-12-26 Farmatron Ltd Composizioni farmaceutiche orali a rilascio immediato del principio attivo
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
KR102139338B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물
KR102139339B1 (ko) * 2013-06-24 2020-07-29 주식회사 엘지생활건강 인돌 화합물을 포함하는 용해도가 개선된 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3237814A1 (de) * 1982-10-12 1984-04-12 Warner-Lambert Co., 07950 Morris Plains, N.J. Wasserfreie emulsionen und verwendung derselben
FR2679903B1 (fr) * 1991-08-02 1993-12-03 Elf Sanofi Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
CO4910129A1 (es) 2000-04-24
ZA9710919B (en) 1999-06-04
RU2174394C2 (ru) 2001-10-10
EE9900206A (et) 1999-12-15
BR9712406A (pt) 1999-08-31
WO1998024430A1 (fr) 1998-06-11
JP2000507618A (ja) 2000-06-20
HUP0001386A3 (en) 2002-03-28
ID23373A (id) 2000-04-20
IS5062A (is) 1999-06-01
NZ335750A (en) 2001-06-29
NO992724L (no) 1999-06-04
YU23099A (en) 1999-11-22
AU716575B2 (en) 2000-03-02
FR2756736A1 (fr) 1998-06-12
SK75599A3 (en) 2000-08-14
NO992724D0 (no) 1999-06-04
IL129936A0 (en) 2000-02-29
CN1239887A (zh) 1999-12-29
MY132819A (en) 2007-10-31
HUP0001386A2 (hu) 2001-04-28
AR009651A1 (es) 2000-04-26
KR20000069308A (ko) 2000-11-25
FR2756736B1 (fr) 1999-03-05
EP0941090A1 (fr) 1999-09-15
CA2273990A1 (fr) 1998-06-11
DZ2362A1 (fr) 2002-12-28
AU5326298A (en) 1998-06-29

Similar Documents

Publication Publication Date Title
TR199901702T2 (tr) N-Sulfonilindolin türevleri içeren farmasötik bilesimler.
TR199900782T2 (tr) 1-benzil-3-(ikameli hetaril)-kaynasmis pirazol türevlerinin kullanimi.
KR890016154A (ko) 서방성 거품억제 첨가제
PT1164842E (pt) Formulacoes liquidas e sistemas de agentes tensioactivos/solventes
YU30402A (sh) Koncentrati suspenzija, mešavina aktivnih materija za zaštitu bilja bez vode, ili sa malo vode
AR018136A1 (es) Composiciones de champu.
TR199903039T2 (tr) Parfüm barindirmayan iki fazli bilesimler ve vücut ve çevre kokusunun düsürülmesi için yöntemler.
AU4398793A (en) Liquid laundry detergent compositions with silicone antifoam agent
TR199802700T2 (tr) Hasere öldürücü bilesimler.
BR9812754A (pt) Sistema de surfactante misto
DE69718705D1 (de) Zusatz für Spritzbeton
ATE477351T1 (de) Korrosionsinhibitierende zusammensetzungen
BR0309234A (pt) Grânulo detergente contendo um tensoativo não-iÈnico e um hidrótropo
TR200003377T2 (tr) Estrojenler ile bütünleşik 2-fenil-1-[4-(2-aminoetoksi)benzil]-indol
KR960041299A (ko) 고형상 채색 재료
ES2094829T3 (es) Agente para la limpieza de alfombras.
CA2393036A1 (en) Stable, high glycerol liquids comprising sulfosuccinic acid monoesters
DK1152811T3 (da) Antiskummiddel og/eller afluftningsmiddel baseret på olie-i-vand-dispergeringer
KR960000205A (ko) 화장품 조성물
DE50203939D1 (de) Feste Wasch-, Spül- und Reinigungsmittel
BR9816029A (pt) Composições detergente
ZA200603164B (en) Improved detergent composition with benefit agents
BR0109752A (pt) Composição sólida seca, e, processo para preparação de composições de limpeza abrasivas lìquidas
EA200000092A1 (ru) Противоаллергические средства
KR980002110A (ko) 강성 이격물을 갖는 혁신적인 실록산 블록 공중합체 및 이의 용도